Beijing Biostar Pharmaceuticals Co., Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Qiu Rongguo, was filed 08 May 2026.
Beijing Biostar Pharmaceuticals Co., Ltd. - B: what insiders have been doing
This page follows insider dealings at Beijing Biostar Pharmaceuticals Co., Ltd. - B as filed with HKEX, a company from the Health Care sector. 2 insiders have disclosed 2 filings since 22 October 2025.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 senior executives.
The latest purchase dates back some time: it was published 184 days ago, on 8 May 2026.
Compared with its exchange (1,314 companies, median 4 filings), a count of 2 filings is below the norm. Our records for Beijing Biostar Pharmaceuticals Co., Ltd. - B go back to 2026, with 2 purchases and no sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -14.6%Entry HK$4.45 · Close 21 Oct 2026 HK$3.80
- -14.6%Entry HK$4.45 · Close 21 Oct 2026 HK$3.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 57,830,299 sharesShareXHKGHKEX:DA20260508E00303Canonical exit: 29 Jun 2026 (T+90)
- 57,830,299 sharesShareXHKGHKEX:DA20260508E00311Canonical exit: 29 Jun 2026 (T+90)
2 of 2 declarations
About Beijing Biostar Pharmaceuticals Co., Ltd. - B
Beijing Biostar Pharmaceuticals Co., Ltd. is a company focused on the development and manufacturing of pharmaceutical products. It is listed on the Hong Kong Stock Exchange under the symbol B.
